Do antineutrophil cytoplasmic antibodies correlate with disease activity in systemic lupus erythematosus?
Konca, K.; Erken, E.; Ozbek, S.
Journal of Rheumatology 23(11): 2007-2008
1996
ISSN/ISBN: 0315-162X PMID: 8923392 Document Number: 457820
Document emailed within 1 workday
Related Documents
Caligaris-Cappio, F.; Bertero, M.T.; Converso, M.; Stacchini, A.; Vinante, F.; Romagnani, S.; Pizzolo, G. 1995: Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity Clinical and Experimental Rheumatology 13(3): 339-343Lolli, C.; Foscoli, M.; Giofrè, R.; Tarquinii, M.; Pasquali, S.; Toschi, G.P. 1993: Cardiac anomalies in systemic lupus erythematosus: their prevalence and relation to duration, disease activity and the presence of antiphospholipid antibodies Giornale Italiano di Cardiologia 23(11): 1125-1134
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
D'Cruz, D.P.; Mellor-Pita, S.; Joven, B.; Sanna, G.; Allanson, J.; Taylor, J.; Khamashta, M.A.; Hughes, G.R.V. 2004: Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies Journal of Rheumatology 31(2): 280-285
Gutiérrez-Adrianzén, O.Augusto.; Koutouzov, S.; Mota, R.Maria.Salani.; das Chagas Medeiros, M.Maria.; Bach, J-François.; de Holanda Campos, H. 2006: Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies Journal of Rheumatology 33(8): 1538-1544
Xie, H.; Liu, Z.; Zhu, W. 1997: Significance of antinuclear antibodies for the diagnosis and activity of systemic lupus erythematosus Hunan Yi Ke Da Xue Xue Bao 22(2): 177-178
Zivković, V.; Stanković, A.; Cvetković, T.; Mitić, B.; Kostić, S.; Nedović, J.; Stamenković, B. 2014: Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus Srpski Arhiv Za Celokupno Lekarstvo 142(7-8): 431-436
Font, J.; Cervera, R.; Casals, F.J.; Bové, A.; Guerrero, A.; López-Soto, A.; Ingelmo, M.; Urbano-Márquez, A. 1988: Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus Medicina Clinica 90(12): 490-493
Hosaka, K.; Okada, J.; Ogiwara, A.; Kobayashi, A.; Kondo, H. 1994: Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus Ryumachi 34(1): 22-29
Greco, C.M.; Rudy, T.E.; Manzi, S. 2004: Effects of disease activity, pain, and distress on activity limitations in patients with systemic lupus erythematosus Journal of Rheumatology 31(2): 260-267
Sarkar, R.N.; Bhattacharya, K.; Banerjee, M. 2016: Mean platelet volume as an indicator of disease activity in systemic lupus erythematosus Journal of the Association of Physicians of India 64(1): 68-69
Parker, M.D. 1973: Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease Journal of Laboratory and Clinical Medicine 82(5): 769-775
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Abdel Gawad, E.R.; Mansour, A.I.; Abdel Aziz, Y.A.; Soliman, A.F.; Fawzy, R.M. 2014: Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy Egyptian Journal of Immunology 21(1): 57-65
Blanco-Favela, F.; Quintal-Alvarez, G.; Leaños-Miranda, A. 1999: Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power Journal of Rheumatology 26(1): 55-59
El-Garf, A.; Salah, S.; Shaarawy, M.; Zaki, S.; Anwer, S. 1996: Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations Journal of Rheumatology 23(2): 374-377
Leaños-Miranda, A.; Pascoe-Lira, D.; Chávez-Rueda, K.A.; Blanco-Favela, F. 2001: Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity Journal of Rheumatology 28(7): 1546-1553
Pacilio, M.; Migliaresi, S.; Meli, R.; Ambrosone, L.; Bigliardo, B.; Di Carlo, R. 2001: Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity Journal of Rheumatology 28(10): 2216-2221
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Neville, C.; Clarke, A.E.; Joseph, L.; Belisle, P.; Ferland, D.; Fortin, P.R. 2000: Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity Journal of Rheumatology 27(3): 675-679